392 related articles for article (PubMed ID: 19934346)
1. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells.
Ding SY; Nkobena A; Kraft CA; Markwardt ML; Rizzo MA
J Biol Chem; 2011 May; 286(19):16768-74. PubMed ID: 21454584
[TBL] [Abstract][Full Text] [Related]
3. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
4. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
5. Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.
Markwardt ML; Nkobena A; Ding SY; Rizzo MA
Mol Endocrinol; 2012 Sep; 26(9):1617-29. PubMed ID: 22771492
[TBL] [Abstract][Full Text] [Related]
6. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
7. Nitric Oxide Activates β-Cell Glucokinase by Promoting Formation of the "Glucose-Activated" State.
Seckinger KM; Rao VP; Snell NE; Mancini AE; Markwardt ML; Rizzo MA
Biochemistry; 2018 Aug; 57(34):5136-5144. PubMed ID: 30053375
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic β Cells.
Markwardt ML; Seckinger KM; Rizzo MA
J Biol Chem; 2016 Feb; 291(6):3000-9. PubMed ID: 26698632
[TBL] [Abstract][Full Text] [Related]
9. Chronic ethanol consumption-induced pancreatic {beta}-cell dysfunction and apoptosis through glucokinase nitration and its down-regulation.
Kim JY; Song EH; Lee HJ; Oh YK; Park YS; Park JW; Kim BJ; Kim DJ; Lee I; Song J; Kim WH
J Biol Chem; 2010 Nov; 285(48):37251-62. PubMed ID: 20855893
[TBL] [Abstract][Full Text] [Related]
10. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
11. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
13. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
[TBL] [Abstract][Full Text] [Related]
14. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
[TBL] [Abstract][Full Text] [Related]
15. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two MODY2 mutations with different susceptibility to activation.
Langer S; Platz C; Waterstradt R; Baltrusch S
Biochem Biophys Res Commun; 2015 Sep; 464(4):1113-1119. PubMed ID: 26208450
[TBL] [Abstract][Full Text] [Related]
17. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
Shen Y; Cai M; Liang H; Wang H; Weng J
Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
[TBL] [Abstract][Full Text] [Related]
18. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
19. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]